TARA BURLINGAME: Open Payments
NPI 1154190320 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$315 in 7 payments from 5 companies in 2025. Trend: 2023 $22 · 2024 $710 · 2025 $315
Education: $195Food & beverage: $120
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $219 |
| Eisai Inc. | 1 | $29 |
| AstraZeneca Pharmaceuticals LP | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| SOBI, INC | 1 | $18 |
Products named: Lenvima, ENHERTU, BLENREP, Vyloy, Gamifant.
Industry payments across PA — which companies pay providers there.
